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Integrons are genetic units characterized by the ability to capture and incorporate gene
cassettes, thus can contribute to the emergence and transfer of antibiotic resistance.
The objectives of this study were: (1) to investigate the presence and distribution
of class I and class II integrons and the characteristics of the gene cassettes they
carry in Enterobacteriaceae isolated from nosocomial infections at Zagzig University
Hospital in Egypt, (2) to determine their impact on resistance, and (3) to identify
risk factors for the existence of integrons. Relevant samples and full clinical history
were collected from 118 inpatients. Samples were processed; isolated microbes were
identified and tested for antibiotic susceptibilities. Integrons were detected by polymerase
chain reaction (PCR) and were characterized into class I or II by restriction fragment
length polymorphism (RFLP). Integron-positive isolates were subjected to another PCR
to detect gene cassette, followed by gene cassette sequencing. Risk factors were
analyzed by logistic regression analysis. Seventy-six Enterobacteriaceae isolates were
recognized, 41 of them (53.9%) were integron-positive; 39 strains carried class I and
2 strains carried class II integrons. Integrons had gene cassettes encoding different
combinations and types of resistance determinants. Interestingly, blaOXA129 gene was
found and ereA gene was carried on class I integrons. The same determinants were
carried within isolates of the same species as well as isolates of different species. The
presence of integrons was significantly associated with multidrug resistance (MDR).
No risk factors were associated for integron carriage. We conclude that integrons
carrying gene cassettes encoding antibiotic resistance are significantly present among
Enterobacteriaceae causing nosocomial infection in our hospital. Risk factors for
acquisition remain to be identified.
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Introduction
The widespread use of antibiotics with the intra- and inter-
species transfer of resistant determinants mediated by plasmids,
transposons and gene cassettes in integrons have contributed to
the rapid transmission of drug resistance in bacterial pathogens,
especially among members of the Enterobacteriaceae family
(Cergole-Novella et al., 2011). Integrons are mobile DNA
elements capable of detention and excision of genes, particularly
those responsible for antibiotic resistance. Integrons achieve
this by site-specific recombination (Hall and Collis, 1995). The
different combinations of gene cassettes can contribute to the
diverse genetic organization of integrons. There are five different
classes of integrons, each encoding a distinct integrase gene
(Mazel, 2006). Class I integrons are the most common type
present in clinical isolates of the Enterobacteriaceae (DeLappe
et al., 2003). Class II integrons are associated with the Tn7
transposon, whose transposition activity is directed at specific
attachment sites on chromosomes or plasmids (Rodríguez-
Minguela et al., 2009). Although the class II integrons share their
cassettes pool with the class I integrons, they are distinguished by
divergent integrase sequences (Gillings, 2014). Class I integron
possess two conserved segments (5′-CS) and (3′-CS) separated
by a variable region including the gene cassettes integrated with
antibiotic resistant genes. The 5′-CS consists of (intI) gene codes
for integrase, adjacent recombination site (att1) recognized by
the integrase and acts as a receptor for gene cassettes, and
the promoter (P) which controls the transcription of integrated
resistance markers, as these genes do not have their own
promoters (Mazel, 2006). The 3′-CS usually includes truncated
qacE (qacED1) and sul1 genes that confer resistance to quaternary
ammonium compounds and sulfonamides, respectively (Paulsen
et al., 1993). Gene cassettes typically comprise of a recombination
site (attC) and a single-promoter-less gene, most of which
encode antibiotic resistance factors (Partridge et al., 2009).
Class I integron has been identified as the primary source of
antimicrobial resistance genes and are suspected to serve as
reservoirs and exchange platforms of resistant genes in a variety
of Gram-negative bacteria (Ke et al., 2011).
During the last months, there were complaints from clinicians
about the emergence and dissemination of MDR in the intensive
care unit (ICU), the orthopedic unit, the neonatology unit and
the chest unit. This resistance causes treatment failure, morbidity
and sometimes mortality. Preliminary investigations pointed
TABLE 1 | Origin and type of the strains included in the study.
Origin No. and types of samples Enterobactericae isolates
Endotracheal aspiration Urine Swabs from pus Blood Total
ICU 8 21 11 12 52 42 (80.8%)
Orthopedic unit – 9 4 – 13 8 (61.5%)
Neonatology unit – – – 10 10 6 (60%)
Chest unit 5 4 4 2 15 8 (53.3%)
Surgery unit – 17 11 – 28 12 (42.9%)
Total 13 51 30 24 118 76 (64.4%)
out the possibility of integrons (among other mechanisms of
resistance). To the best of our knowledge, little is known
about the integrons and their associated gene cassettes in
Enterobacteriaceae isolates in our hospital specifically, in Egypt
generally. In order to provide helpful base-line information for
further comparison with follow up studies, we thus conducted
the current work. The objectives were: (1) to investigate the
presence and distribution of class I and class II integrons
and the characteristics of the gene cassettes they carry in
Enterobacteriaceae isolated from nosocomial infection cases at
Zagzig University Hospital, (2) to determine their impact on
resistance, and (3) to identify risk factors of the existence of
integrons.
Materials and Methods
Subjects
Over a period of 23 months (May 2012–March 2014), 118
in-patients were enrolled from different clinical departments
at Zagazig University Hospital. Patients were included only if
they are suspected to have hospital-acquired infection (Horan
et al., 2008) and the laboratory results reported Gram-negative
bacilli from the infection sites. Clinical units selected were those
reported to the Infection Control Unit as having increased
incidence of infections caused by resistant-Enterobacteriaceae.
The demographic and clinical data was collected from all
patients.
Ethical Consideration
An informed written consent was taken from each individual
after explaining the nature of investigation as well as the
purpose of the study in accordance with the ethical standards
of the responsible Regional Committee. Participants’ data is
confidential. Institutional approval was obtained from the
Institutional Review Board (IRB) committee.
Study Design
Observational cross sectional study.
Clinical Samples
Clinical samples were collected by systematic random sampling.
The origin and type of samples are shown in Table 1. Samples
were collected and processed using standard Microbiologic
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procedures (Collee and Marr, 1996; Raul and Melvin, 2001;
Cheesbrough, 2004; Forbes et al., 2007); isolated microbes
were identified by colonial characteristics, Gram stain and
conventional biochemical tests and confirmed by the API 20E
Identification System (bioMerieux, France).
Antibiotic Susceptibility
Antimicrobial susceptibility profiles of the isolates were
determined using the disk diffusion method according to
the standard procedures of the Clinical and Laboratory
Standards Institute (CLSI, 2013). Escherichia coli (ATCC25922)
(Microbiologics, USA) was used as the quality control
strain. The following 17 antibiotic discs (Oxoid) were used:
amikacin, amoxicillin+clavulanic acid, ampicillin+sulbactam,
azithromycin, cefepime, cefixime, cefotaxime, cefoxitin,
cefperazone, ceftazidime, ceftriaxone, chloramphenicol,
gentamycin, imipenem, levofloxacin, meropenem, and
trimethoprim-sulphamethexazole. MDR was defined according
to the guidelines of the European Society of Clinical
Microbiology and Infectious Diseases (Magiorakos et al.,
2012).
Molecular Characterization of Isolated
Enterobacteriaceae
Integrons Detection
DNA was extracted from overnight cultures grown on
MacConkey’s agar, using the QIAamp DNA Mini Kit (QIAGEN,
USA), according to the manufacturer’s instructions. The DNA
was quantified following the recommendations of Surzycki
(2000).
PCR Detection of Integrons
Integrons were detected by PCR with the degenerate primers
designed to hybridize conserved regions of encoded integrase
genes intI1, intI2, hep35 (5′-TGCGGGTYAARGATBTKGATTT-
3′), and hep36 (5′-CARCACATGCGTRTARAT-3′) give a PCR
product of 491 bp (White et al., 2001).
RFLP for Differentiation of Class I and Class II
Integrons
Digestion of PCR Product
Using Rsa I restriction enzyme (White et al., 2001), PCR products
were subjected to digestion with Rsa I as follow, 10µl of the
amplified gene segment, 2µl of the l0x buffer supplied, 1µl of
the enzyme and complete reaction with sterile water to attain the
final volume of 20µl, which was incubated for 3 h at 37◦C. Then,
the total volume was loaded on the agarose gel. After digestion,
integrase I gave rise to one fragment of 491 bp, while integrase II
gave rise to two fragments of 334 and 157 bp, respectively.
Amplification of Gene Cassettes of Class I and Class
II Integrons
Class I integron cassette structures were amplified using
hep58 (5′-TCATGGCTTGTTATGACTGT3-3′) and hep59
(5′-GTAGGGCTTATTATGCACGC-3′) which bind 3′-
CS and 5′-CS conserved segments, respectively. Class II
integron cassette regions were amplified using hep74 (5′-
CGGGATCCCGGACGGCATGCACGATTTGTA-3′), which
binds to attI2 and hep51 (5′-GATGCCATCGCAAGTACGAG-
3′), which binds to orfX situated downstream of the cassette
region within Tn7 (GenBank accession number AJ002782)
(White et al., 2001). PCR was performed for 30 cycles, each cycle
consisted of 94◦C for 30 s, 55◦C for 30 s and extension at 72◦C
for 45 s for amplification of the integrase genes, or 4min for
amplification of the cassette region. Amplification cycles were
performed with DNA thermal cycler (Biometra, Germany), as
mentioned elsewhere (White et al., 2000). For each batch of PCR
reactions, a positive and negative control was included. Positive
control was an isolate confirmed as integrase positive by DNA
sequencing. PCR products were analyzed in parallel with a DNA
MW-marker (Fermentas) by electrophoresis on 2% agarose gel.
DNA Sequencing
Sequencing reactions were performed through using the
BigDye Terminator version 3.1 Cycle Sequencing Kit (Applied
Biosystems). Each reaction mixture contained 8µl of the BigDye
Terminator ready reaction mixture and 3.2 pmol of primer
in a 20µl reaction mixture. The PCR products of inserted
gene cassettes within class I intgrons were sequenced using
primers hep58, 5′-TCATGGCTTGTTATGACTGT-3′ and hep59,
5′-GTAGGGCTTATTATGCACGC-3′. The PCR program for
all sequencing reactions included initial denaturation at 96◦C
for 1min, followed by 25 cycles of denaturation for 30 s
at 96◦C, primer annealing for 5 s at 55◦C, and extension
for 4min at 60◦C according to the BigDye Terminator v3.1
Cycle Sequencing Kit Protocol Manual. The resulting sequences
were identified by partial nucleotide sequencing and compared
with the sequences in the GenBank database of the National
Center for Biotechnology Information via the BLAST network
service (http://blast.ncbi.nlm.nih.gov/Blast.cgi) (Li et al., 2013).
MEGABLASTmodel of BLAST programwas used. The best Blast
Hits on our Query nucleotide sequence was selected based on the
highest identity in the gene bank database.
Statistical Analysis
Collected data were computerized and statistically analyzed using
SPSS program (Statistical Package for Social Science) version
18.0. Qualitative data were represented as frequencies and relative
percentages. Chi square test was used to calculate difference
between qualitative variables. Quantitative data were expressed as
mean± SD (Standard deviation). Multivariate logistic regression
analysis was used to illuminate the interrelation within and
between significant predictors for specific variable. The level of
significance for all statistical tests was determined. The threshold
of significance is fixed at 5% level (P-value); P > 0.05 indicates
non-significant results, P-value of <0.05 indicates significant
results.
Results
Seventy-six Enterobacteriaceae isolates were studied. They
were recovered from different clinical samples collected from
118 in-patients admitted to different departments at Zagazig
University Hospitals (Table 1). The highest rate of isolating
Enterobacteriaceae was from ICU (42 out of 76).
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FIGURE 1 | Distribution of different species of Enterobacteriacae.
TABLE 2 | Detection of class I and class II integrons by PCR–RFLP.
Enterobacteriaceae isolates Class I Class II Total
Organism No. No. (%) No. (%) No. (%)
Klebsiella pneumonia 40 17 (42.5) 1 (2.5) 18 (45)
Escherichia coli 18 14 (77.8) 1 (5.5) 15 (83.3)
Enterobacter cloaca 3 1 (33.3) 2 (66.6)
Citrobacter freundii 2 1 (50) 1 (50)
Serratia marcescens 2 1 (50) 1 (50)
Morganella morgani 1 0 (0.0) 0 (0.0)
Proteus mirabialis 6 3 (50) 3 (50)
Proteus vulgaris 3 1 (33.3) 1 (33.3)
Citrobacter breakie 1 0 (0.0) 0 (0.0)
Total 76 39 (51.32) 2 (2.6) 41 (53.9)
Characterization of different species of Enterobacteriaceae
is shown in Figure 1. Klebsiella pneumoniae was the most
common organism isolated (50.6%). Integrons were identified in
41 (53.9%) out of the 76 strains studied (Table 2). Thirty-nine
(39) carried class I integron and 2 strains carried class II integron
Figures 2, 3.
Sequencing of PCR product of gene cassettes carried
on class I integron revealed different combination of gene
cassettes encoding the different types of resistance determinants.
Interestingly, blaOXA129 gene was found and ereA gene was
detected on class I integrons. The same determinants were carried
within isolates of the same species as well as isolates of different
species (Table 3).
Isolates harboring integrons were more likely to be resistant to
amikacin, cefepime, ceftazidime, ceftriaxone, chloramphenicol,
gentamycin, levofloxacin, and trimethoprim-sulphamethexazole
than those without integrons (Table 4). All Enterobacteriaceae
isolates were sensitive to both imipenem and meropenem;
therefore, carbapenems group was excluded from statistical
analysis. Fifty-one isolates were found to be MD-resistant
(Table 5). A significant statistical association was found between
MDR and the presence of integrons (Table 6).
FIGURE 2 | Ethidium bromide-stained agrose gel showing +ve isolates
for integrase gene. Lane M: molecular size marker (100–1000). Lane 1:
positive control. Lanes 2–6: 491 (bp PCR product from positive strains). Lane
7: negative control.
FIGURE 3 | Ethidium bromide stained agrose gel showing +ve class I
and class II integron with RFLP by restriction enzyme digestion. Lane
M: molecular size marker (100–1000). Lanes 1, 2: 2 segments (bands) 334,
157 bp, respectively. Lanes 3–6: 491 (bp PCR product class 1 positive strain).
Lane 7: negative control.
Preliminary analysis using Chi square test revealed admission
to ICU, trauma and hospitalization more than 7 days to
be significantly correlated with integron positivity (Table 7).
However, logistic regression analysis revealed no significant
association (Table 8).
Discussion
Members of the family Enterobacteriaceae are frequently
identified as etiological agents of nosocomial infections (Holt
et al., 1994; Obeng-Nkrumah et al., 2013). Hospitalized patients,
especially those admitted to ICUs, are at high risk (Archibald
et al., 1997; El-Bialy and Abu-Zeid, 2009; Elsharkawy et al., 2013).
This could explain the highest rate of isolating Enterobacteriaceae
from the ICU encountered in the current work (Table 1), which
support findings of others (Obeng-Nkrumah et al., 2013). In our
study Klebsiella pneumoniae was the most commonly isolated
organism, followed by Escherichia coli (Figure 1). This agrees
with Abdel-Hady et al. (2008), Obeng-Nkrumah et al. (2013) and
Defife et al. (2009), but disagrees with Asencio et al. (2014). The
differences can be due to variations in study population, sample
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TABLE 3 | Occurrence and characterization of gene cassettes carried by
of class I integrons.
Bacterial species Gene cassette(s) No.
K. pneumonia dfrA14-arr2-cmiA 5 2
blaOXA-1-aac A6-dfrA 5 2
dfrA5-aph 31a 2
dfrA5-TEM−1 1
OXA 129-dfrA5-aacA4 1
dfrA 3
aacC1-aadA1 1
aadA1-dfrA1 3
aadA2 2
aadA-qac-e 2
E. coli aadB 1
aadA1-dfrA1 2
AadA 3
aac6 II- 2
ere A2-dfr A5 2
Not determined 2
P. mirabilis ere A2-dfr A5 2
Not determined 1
E. cloaca dfr A5 1
DfrA1-aadA2 1
S. marcescens blaP1-aadB 1
C. freundii dfrA-aadA5-qac-e 1
P. vulgaris OXA 129-dfrA5-accA4 1
dfr, Dihydrofolate reductases; arr, rifampicin resistance; cmi, chloramphenicol
resistance protein; OXA, oxasillinase; aac, aminoglycoside acetyltransferases; aph,
3-O-phosphotransferase; aad, aminoglycoside adenylyltransferases B; qac, quaternary
ammonium compound; TEM, beta lactamase gene; bla P, beta lactamase gene.
size, the presence of an epidemic as well as dissimilarities in
antibiotic use.
The rate of integron-positive Enterobacteriaceae identified
in this work is 53.9% compared to what was previously
reported (White et al., 2001; Kor et al., 2013). We found
the highest percentage of integrons in Escherichia coli (83.3%)
which correlate with the report of Essen-Zandbergen et al.
(2007), but not with Daikos et al. (2007) (Table 2). This
could be attributed to diverse geographical distribution. The
predominance of class I integrons among our isolates agree with
many workers (Chang et al., 2000; White et al., 2001; Kor et al.,
2013).
PCR product of cassette regions of class I integron were
sequenced. The cassette regions of three class I integrons could
not be amplified, possibly due to the lack of a 3′-conserved
segment or due to presence of early stop codon (Ramírez et al.,
2010). It is worth mentioning that the number and combination
of genes found in gene cassettes of our isolate are different from
that reported by many other researchers (White et al., 2001;
Leverstein-van Hall et al., 2002; Kang et al., 2005), which prove
the effect of geographic difference on integron distribution (Yu
et al., 2004). Class II integons were excluded from sequencing
analysis due to the very small sample size which limits the power
of any conclusions (Table 3).
TABLE 4 | Association between antibiotic resistance and integron
positivity.
Antibiotic Resistant Integron +ve P
No. (%) No. (%)
Amikacin 22 31.5 18 81.8 0.0164
Amoxicillin+clavulanic 76 100 40 52.6 0.779
Ampicillin+sulbactam 66 86.8 35 35.03 0.7634
Azithromycin 64 84.2 35 54.7 0.646
Cefepime 47 61.8 33 70.3 0.0302
Cefixime 34 44.7 18 52.9 0.731
Cefotaxime 45 59.2 25 55.6 0.586
Cefoxitin 25 32.8 11 44.0 0.806
Cefperazone 51 67.1 36 70.6 0.169
Ceftazidime 44 57.8 29 65.9 0.0163
Ceftriaxone 53 69.7 39 73.6 0.006
Chloramphenicol 20 26.3 16 80.0 0.0293
Gentamycin 29 28.9 23 79.3 0.0108
Levofloxacin 11 14.4 10 90.9 0.0273
Trimethoprim-sulphamethexazole 48 63.1 39 81.3 0.001
Level of significance: P < 0.05 indicates significant results.
In this study, class I integrons harbored different cassette
arrays conferring resistance to nearly every major class of
antibiotics, with the remarkable exception of the quinolones
(Daikos et al., 2007; Essen-Zandbergen et al., 2007). The most
common types were those conferring resistance to trimethoprim
antibiotic (dfr) a finding in agreement with Daikos et al. (2007)
and Essen-Zandbergen et al. (2007). The high prevalence of dfr
gene cassettes may be due to the wide use of trimethoprim
as a first line therapy for the treatment of urinary tract
infections, a clinical condition that is very common in both
hospital and community settings. Another common types of
cassette carried by class I integrons were those conferring
resistance to streptomycin and spectinomycin (White et al.,
2001). Aminoglycoside resistance genes (aadB, aac, and aph)
encoding resistance to aminoglycosides other than streptomycin
and spectinomycin (gentamicin, kanamycin, and amikacin) were
found in 11 of our isolates. The selective pressure exerted by
aminoglycosides intensively used in our hospitals might account
for this finding (Table 3). Resistance to beta-lactam antibiotic
was represented in this work by four cassettes (bla OXA 129-
OXA 1-TEM-blaP1). To the best of our knowledge, bla OXA
129 is detected for the first time in Egypt. Till date, only two
reports are available on the presence of OXA 129 in Gram-
negative bacteria. The first was in 2008 from Brazil, from
Salmonella enterica subsp. enterica serovar Bredeney porcine
isolates (Michael et al., 2008), and the second was from China,
in 2010 from Pseudomonas aeruginosa (Liu et al., 2010). The
blaOXA-1 gene was found in two of our isolates. All the
genes for the OXA-1-like beta-lactamases were identified in the
form of gene cassettes inserted into class I integrons (Naas
and Nordmann, 1999; Aubert et al., 2001; Dubois et al., 2003;
Poirel et al., 2004). Other cassettes detected were those for
erythromycin (ereA2), and for rifampicin resistance. These two
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TABLE 5 | Resistance profile of 51 MDR* isolate.
Bacterial isolates Antimicrobial categories MDR(51)
Integron+ve (33) Integron −ve (18)
Klebsiella pneumoniae Aminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors,
penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins
5 1
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase
inhibitors, cephamycins
8 4
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+b-lactamase,
quinolones, aminoglycosides
3 0
Penicillins+b-lactamase inhibitors, chloramphenicol, cephamycins 1 1
Extended-spectrum cephalosporins, penicillins+β-lactamase inhibitors, chloramphenicol,
cephamycins
0 4
Escherichia coli Penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins 3 2
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase
inhibitors, quinolones
2 1
Aminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors,
penicillins+β-lactamase inhibitors, Chloramphenicol, Cephamycins
2 1
Proteus mirabilis Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase
inhibitors
1 2
Folate pathway inhibitors, penicillins+β-lactamase inhibitors, cephamycins 1 0
Proteus vulgaris Aminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors,
penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins
1 0
Aminoglycosides; folate pathway inhibitors, penicillins+β-lactamase inhibitors,
chloramphenicol, cephamycins, quinolones
1 1
Serratia marcescens Aminoglycosides, extended-spectrum cephalosporins; folate pathway inhibitors,
penicillins+β-lactamase inhibitors, chloramphenicol, cephamycins
1 0
Extended-spectrum cephalosporins; folate pathway inhibitors, penicillins+β-lactamase
inhibitors, cephamycins, quinolones
1 0
Citrobacter freundii Aminoglycosides, Extended-spectrum cephalosporins; folate pathway inhibitors,
penicillins+β-lactamase inhibitors, cephamycins
1 0
Enterobacter cloaca Folate pathway inhibitors, penicillins+β-lactamase inhibitors, cephamycins, quinolones,
chloramphenicol
1 1
Morganella morgani Aminoglycosides, Extended-spectrum cephalosporins; folate pathway inhibitors,
penicillins+β-lactamase inhibitors, chloramphenicol cephamycins
1 0
*Categories used in this table to identify MDR are those recommended by the European Society of clinical Microbiology and Infectious Diseases (Magiorakos et al., 2012): 1,
aminoglycosides: gentamicin, amikacin; 2, carbapenems: imipenem, meropenem; 3, extended-spectrum cephalosporins (third and fourth generation cephalosporins); cefotaxime or
ceftriaxone, ceftazidime, cefepime; 4, cephamycins: cefoxitin; 5, quinolones: ciprofloxacin, levofloxacin; 6, folate pathway inhibitors: trimethoprim-sulphamethoxazole; 7, Penicillins +
β-lactamase inhibitors: amoxicillin-clavulanic, ampicillin-sulbactam; 8, Phenicols: chloramphenicol.
gene cassettes were identified relatively more recently than the
other cassettes (Jones et al., 1997; Tribuddharat and Fennewald,
1999; Leverstein-van Hall et al., 2002). The ereA gene cassette
carries its own promoter and is propagated by a class II integron
(Biskri and Mazel, 2003). Recently, a cassette carrying a gene
and showing about 90% identity with ereA was identified in a
class I multi-resistant integron (MRI) (Chang et al., 2000; Peters
et al., 2001; Thungapathra et al., 2002; Plante et al., 2003). In this
study, the occurrence of ereA gene carried on class I integron
on four isolates (Table 3) is reported in Egypt for the first
time. Chloramphenicol resistance protein (exporter), (cmiA5),
were detected in two isolates. This gene is responsible for a
less prevalent non-enzymatic mechanism of chloramphenicol
resistance observed principally in Gram-negative bacteria
(Bissonnette et al., 1991). The extremely low occurrence of
chloramphenicol resistance, through a less prevalent mechanism
presented by gene cassettes of our isolates, can be explained by
the fact that chloramphenicol is no more prescribed in hospitals
for the fear of its complications. Cassette (qac-e) which encodes
for quaternary ammonium compounds resistance was detected
in three of our isolates. In Enterobacteriaceae, the qac genes
have been most regularly found together with genes coding for
resistance to chloramphenicol, aminoglycosides, beta-lactams,
sulphonamides and trimethoprim (Poirel et al., 2000; Riaño et al.,
2006; Espedido et al., 2008; Zhao et al., 2012). In our work,
qac-e has been found together with genes encoding resistance to
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TABLE 6 | Relation between integron presence and MDR among
Enterobactericae isolates.
Integron Antibiotic χ2 P-value
MDR* Other isolates
No. (%) No. (%)
Integron +ve (N = 41) 33 (64.7) 9 (36) 4.491 0.017*
Integron −ve (N = 35) 18 (35.3) 16 (64)
Total 51 (100) 25 (100)
χ
2, Chi square test; *level of significans (p < 0.05).
TABLE 7 | Association between risk factors and presence of integron (Chi
square test).
Risk factor No. of cases Integron Integron P-value
+ve −ve
No % No %
Trauma 55 38 69.1 17 30.9 0.029*
Hospitalization
more than 7 days
20 17 85 3 15 0.011*
ICU admission 34 29 85.3 5 14.7 0.002*
Ventilator 10 8 80 2 20 0.235
Urinary catheter 28 7 25 21 75 0.357
Central venous
catheter
5 4 80 1 20 0.586
*Chi square test.
TABLE 8 | Logistic regression analysis for significant predictors of the
presence of integron among the studied groups.
Variable B S.E. Wald Sig. OR
Trauma 22.02 7.26 0.02 0.98 3.64 (0.07–5.15)
Hospitalization more
than 7 days
20.17 8.27 0.04 0.96 5.73 (1.02–7.45)
ICU admission 42.03 1.10 0.03 0.90 0.01 (0.00–0.06)
B, Regression coefficients; S.E., standard error around the coefficient for the constant;
Wald, Wald chi-square test statistic; Sig. P-value for Wald test; OR, odds ratio.
aminoglycosides, and sulphonamides (Table 3). The correlation
between the qac genes and macrolide inactivation genes was
reported in Aeromonas hydrophila (Poole et al., 2006) and in
microflora from a wastewater treatment unit (Szczepanowski
et al., 2004). Hence, the use of several cationic biocides may
also be accountable for the selection of bacteria resistant to
antimicrobials (Russell, 2000).
It is worth mentioning that not only particular genes are
shared across species but also some gene combinations. In the
current work, dfrA5 was present across Klebsiella pneumoniae,
Escherichia coli, Proteus mirabilis, Enterobacter cloaca, and
Proteus vulgaris. Gene combination, aadA1-dfrA1, was identified
in Klebsiella pneumonia and Escherichia coli; the combination
comprised of ereA2-dfrA5 was detected in Escherichia coli and
Proteus mirabilis (Table 3). We also observed the presence of
more than one isolate of Klebsiella pneumoniae, Escherichia coli
and Proteus mirabilis carrying a particular integron (Table 3).
Since all these gene cassettes are carried by class I integron
which contains integrase 1 (conserved sequence) (White et al.,
2001), the transfer of the integrons by both intra- and inter-
species is assumed. Integron spread may be achieved through
the cross-transmission of integron-carrying clones from one
patient to the other, an action known to be facilitated among
Enterobacteriaceae in hospital settings (Leverstein-van Hall et al.,
2002). This is particularly important in the background of poor
compliance with infection control in our hospital.
The phenotypic resistance to a specific drug was observed
in all isolates carrying the corresponding gene cassette; this
coincides with Leverstein-van Hall et al. (2002); Barlow et al.
(2004); Kor et al. (2013), and Li et al. (2013). However, it
is also evident that integron-carrying organisms had reduced
susceptibility not only to antimicrobial agents for which the
respective gene cassettes were contained in but also to other
classes of agents for which no or very little number of genes
are contained within the integrons. In the current work, this
applies to the third generation cephalosporins, chloramphenicol,
and quinolones. Thus, we support the finding of previous
investigators (White et al., 2001; Leverstein-van Hall et al.,
2002; Essen-Zandbergen et al., 2007) regarding cephalosporins.
Remarkably, not all the resistance profile of the isolates could be
explained by the expression of the gene cassettes found within
the integrons. Apparently a considerable number of antibiotic
resistance genes are located outside the integrons either on
chromosomes or plasmids.
More than half of our isolates were MD-resistant (Tables 5,
6) which has also been concluded by other workers (Elsharkawy
et al., 2013; Ali et al., 2014). Just as reported by Partridge
et al. (2009), class I integrons are significantly associated
with MDR.
Logistic regression analysis for risk factors of the presence
of integron among the studied group revealed statistically non-
significant results (Table 8), which correlate with findings of
Daikos et al. (2007). It may be due to small sample size. Hence,
further investigation on a larger sample size is recommended.
We conclude that integrons carrying gene cassettes
encoding antibiotic resistance are significantly present among
Enterobacteriaceae causing nosocomial infection in our hospital.
We also report for the first time in Egypt the detection of
blaOXA129 and the carriage of ereA gene on class I integrons.
These existences have important implications. Unless the use
of antimicrobials in our hospital is rationalized, the emergence
and the dissemination of these genes as well as other encoding
resistance to more antibiotics will be evident in the future.
Our study has renewed interest in the use of chloramphenicol
since it is an effective and a cheap antimicrobial. In low-income
countries, the use of chloramphenicol should be encouraged. The
use of several cationic biocides should also be appropriate, since
inappropriate usage may account for the selection of bacteria
resistant to antimicrobials. A significant relationship was found
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between integron and MD-resistant phenotype. It is to be
emphasized that the continuing use of antibiotics will drive the
numbers of MDR to swell. The risk factors of integron carriage
need to be identified. Our study is providing the base-line
information that can be helpful in further monitoring and for
evaluation.
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